Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.

J Clin Med. 2019 Nov 18;8(11). pii: E2013. doi: 10.3390/jcm8112013.

2.

Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate?

Cavazzana I, Vizzardi E, Franceschini F.

Monaldi Arch Chest Dis. 2019 Sep 10;89(3). doi: 10.4081/monaldi.2019.1137.

3.

Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.

Cavazzana I, Richards M, Bentow C, Seaman A, Fredi M, Giudizi MG, Palterer B, Pratesi F, Migliorini P, Franceschini F, Satoh M, Ceribelli A, Mahler M.

J Immunol Methods. 2019 Nov;474:112661. doi: 10.1016/j.jim.2019.112661. Epub 2019 Aug 21.

4.

Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?

Cavazzana I, Fredi M, Franceschini F.

Ann Rheum Dis. 2019 Jul 15. pii: annrheumdis-2019-215884. doi: 10.1136/annrheumdis-2019-215884. [Epub ahead of print] No abstract available.

PMID:
31308068
5.

Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.

Cavazzana I, Kumar R, Pozzari C, Ottaviani R, Fredi M, Piantoni S, Andreoli L, Tincani A, Franceschini F.

Lupus. 2019 Aug;28(9):1074-1081. doi: 10.1177/0961203319860191. Epub 2019 Jul 11.

PMID:
31296140
6.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

7.

C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.

Fredi M, Cavazzana I, Biasiotto G, Filosto M, Padovani A, Monti E, Tincani A, Franceschini F, Zanella I.

Neuromolecular Med. 2019 Jun;21(2):150-159. doi: 10.1007/s12017-019-08528-8. Epub 2019 Mar 11.

PMID:
30859373
8.

Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors.

Cavazzana I, Piantoni S, Sciatti E, Fredi M, Taraborelli M, Bonadei I, Airò P, Metra M, Tincani A, Franceschini F, Vizzardi E.

Lupus. 2019 Feb;28(2):210-216. doi: 10.1177/0961203318821161. Epub 2019 Jan 4.

PMID:
30608206
9.

Systemic Lupus Erythematosus and Endothelial Dysfunction: A Close Relationship.

Sciatti E, Cavazzana I, Vizzardi E, Bonadei I, Fredi M, Taraborelli M, Ferizi R, Metra M, Tincani A, Franceschini F.

Curr Rheumatol Rev. 2019;15(3):177-188. doi: 10.2174/1573397115666181126105318.

PMID:
30474532
10.

Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?

Cavazzana I, Alberici A, Bonomi E, Ottaviani R, Kumar R, Archetti S, Manes M, Cosseddu M, Buratti E, Padovani A, Tincani A, Franceschini F, Borroni B.

J Neuroimmunol. 2018 Dec 15;325:61-63. doi: 10.1016/j.jneuroim.2018.10.006. Epub 2018 Oct 19.

PMID:
30391902
11.

The clinico-serological spectrum of overlap myositis.

Fredi M, Cavazzana I, Franceschini F.

Curr Opin Rheumatol. 2018 Nov;30(6):637-643. doi: 10.1097/BOR.0000000000000536. Review.

PMID:
30074509
12.

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.

Dall'Ara F, Cavazzana I, Frassi M, Taraborelli M, Fredi M, Franceschini F, Andreoli L, Rossi M, Cattaneo C, Tincani A, Airò P.

Reumatismo. 2018 Jul 6;70(2):100-105. doi: 10.4081/reumatismo.2018.1023.

13.

Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Cavazzana I, Andreoli L, Limper M, Franceschini F, Tincani A.

Curr Rheumatol Rep. 2018 Mar 15;20(3):15. doi: 10.1007/s11926-018-0718-4. Review.

PMID:
29541874
14.

Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.

Calise SJ, Zheng B, Hasegawa T, Satoh M, Isailovic N, Ceribelli A, Andrade LEC, Boylan K, Cavazzana I, Fritzler MJ, de la Torre IG, Hiepe F, Kohl K, Selmi C, Shoenfeld Y, Tincani A, Chan EKL; IUIS Autoantibody Standardization Committee.

Clin Chem Lab Med. 2018 Sep 25;56(10):1789-1798. doi: 10.1515/cclm-2017-1152. No abstract available.

PMID:
29478040
15.

Endothelial Dysfunction in Early Systemic Lupus Erythematosus Patients and Controls Without Previous Cardiovascular Events.

Taraborelli M, Sciatti E, Bonadei I, Terlizzi V, Fredi M, Zani R, Cancarini G, Tincani A, Franceschini F, Vizzardi E, Cavazzana I.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1277-1283. doi: 10.1002/acr.23495. Epub 2018 Aug 16.

16.

The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature.

Rigon A, Infantino M, Merone M, Iannello G, Tincani A, Cavazzana I, Carabellese N, Radice A, Manfredi M, Soda P, Afeltra A.

Autoimmun Rev. 2017 Dec;16(12):1224-1229. doi: 10.1016/j.autrev.2017.10.006. Epub 2017 Oct 14. Review.

PMID:
29037905
17.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

18.

Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies.

Fredi M, Cavazzana I, Zanola A, Carabellese N, Tincani A, Mahler M, Franceschini F.

Lupus. 2017 Sep;26(10):1121-1122. doi: 10.1177/0961203317696592. Epub 2017 Mar 10. No abstract available.

PMID:
28420064
19.

Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.

Taraborelli M, Cavazzana I, Martinazzi N, Lazzaroni MG, Fredi M, Andreoli L, Franceschini F, Tincani A.

Lupus. 2017 Oct;26(11):1197-1204. doi: 10.1177/0961203317693096. Epub 2017 Feb 22.

PMID:
28420047
20.

The 2016 classification criteria for primary Sjogren's syndrome: what's new?

Franceschini F, Cavazzana I, Andreoli L, Tincani A.

BMC Med. 2017 Mar 31;15(1):69. doi: 10.1186/s12916-017-0837-1.

21.

Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures.

Scanzi F, Andreoli L, Martinelli M, Taraborelli M, Cavazzana I, Carabellese N, Ottaviani R, Allegri F, Franceschini F, Agmon-Levin N, Shoenfeld Y, Tincani A.

Immunol Res. 2017 Feb;65(1):150-156. doi: 10.1007/s12026-017-8912-4.

PMID:
28332072
22.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Review.

PMID:
28147261
23.

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.

Lazzaroni MG, Cavazzana I, Colombo E, Dobrota R, Hernandez J, Hesselstrand R, Varju C, Nagy G, Smith V, Caramaschi P, Riccieri V, Hachulla E, Balbir-Gurman A, Chatelus E, Romanowska-Próchnicka K, Araújo AC, Distler O, Allanore Y, Airò P; EUSTAR co-authors.

J Rheumatol. 2017 May;44(5):639-647. doi: 10.3899/jrheum.160817. Epub 2017 Jan 15.

PMID:
28089973
24.

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.

Taraborelli M, Lazzaroni MG, Martinazzi N, Fredi M, Cavazzana I, Franceschini F, Tincani A.

Reumatismo. 2016 Dec 16;68(3):137-143. doi: 10.4081/reumatismo.2016.891.

25.

Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.

Fredi M, Bartoli F, Cavazzana I, Ceribelli A, Carabellese N, Tincani A, Satoh M, Franceschini F.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):303-308. Epub 2016 Nov 14.

26.

Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.

Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C.

Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20.

27.

Antibodies against antigens related to scleroderma in a cohort of patients with morphea.

Arisi M, Cavazzana I, Cerutti ME, Ferrari F, Carabellese N, Rossi MT, Tincani A, Calzavara-Pinton P, Franceschini F.

G Ital Dermatol Venereol. 2018 Aug;153(4):451-458. doi: 10.23736/S0392-0488.16.05464-X. Epub 2016 Oct 5.

PMID:
27706114
28.

Left ventricular function in rheumatoid arthritis during anti-TNF-α treatment: a speckle tracking prospective echocardiographic study.

Vizzardi E, Cavazzana I, Franceschini F, Bonadei I, Sciatti E, Lombardi CM, Tincani A, Metra M.

Monaldi Arch Chest Dis. 2016 Jun 22;84(1-2):716. doi: 10.4081/monaldi.2015.716.

29.

Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.

Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, Tincani A, Satoh M, Franceschini F.

J Immunol Methods. 2016 Jun;433:1-5. doi: 10.1016/j.jim.2016.02.017. Epub 2016 Feb 18.

PMID:
26906088
30.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Review.

PMID:
26782036
31.

Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors.

Vizzardi E, Bazzani C, Cavazzana I, Sciatti E, Bonadei I, Franceschini F, Tincani A, Metra M.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):352. Epub 2015 Dec 1. No abstract available.

PMID:
26632765
32.

The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Cavazzana I, Fredi M, Selmi C, Tincani A, Franceschini F.

Clin Rev Allergy Immunol. 2017 Feb;52(1):88-98. doi: 10.1007/s12016-015-8517-4. Review.

PMID:
26514357
33.

Dr. Reggia, et al, reply.

Reggia R, Tincani A, Franceschini F, Cavazzana I.

J Rheumatol. 2015 Oct;42(10):1995. doi: 10.3899/jrheum.150688. No abstract available.

PMID:
26429209
34.

Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients.

Codullo V, Cereda E, Klersy C, Cavazzana I, Alpini C, Bonardi C, Turri A, Franceschini F, Caccialanza R, Montecucco C, Caporali R.

Rheumatology (Oxford). 2016 Feb;55(2):315-9. doi: 10.1093/rheumatology/kev322. Epub 2015 Sep 10.

35.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

36.

Switching from intravenous to subcutaneous formulation of abatacept: a single-center Italian experience on efficacy and safety.

Reggia R, Franceschini F, Tincani A, Cavazzana I.

J Rheumatol. 2015 Feb;42(2):193-5. doi: 10.3899/jrheum.141042. Epub 2014 Dec 15.

PMID:
25512476
37.

Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review.

Lubrano E, Spadaro A, Amato G, Benucci M, Cavazzana I, Chimenti MS, Ciancio G, D Alessandro G, Angelis R, Lupoli S, Lurati AM, Naclerio C, Russo R, Semeraro A, Tomietto P, Zuccaro C, De Marco G.

Semin Arthritis Rheum. 2015 Apr;44(5):542-550. doi: 10.1016/j.semarthrit.2014.09.012. Epub 2014 Sep 28. Review.

PMID:
25450240
38.

Evaluation of ascending aorta wall in rheumatoid arthritis by tissue and strain Doppler imaging during anti-tumor necrosis factor-α therapy.

Vizzardi E, Cavazzana I, Sciatti E, Bonadei I, D'Aloia A, Tincani A, Franceschini F, Metra M.

Clin Cardiol. 2014 Dec;37(12):738-43. doi: 10.1002/clc.22332. Epub 2014 Sep 18.

39.

Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis.

Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):732-4. Epub 2014 Sep 8.

PMID:
25198168
40.

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.

Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C, Chan JY, Chan EK, Satoh M, Franceschini F.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):891-7. Epub 2014 Aug 15.

PMID:
25151986
41.

Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.

Taraborelli M, Cavazzana I, Fredi M, Airò P, Nascimbeni G, Tincani A, Franceschini F.

Clin Rheumatol. 2015 Apr;34(4):791-4. doi: 10.1007/s10067-014-2694-z. Epub 2014 Jun 11.

PMID:
25028250
42.

Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide.

Taraborelli M, Monari P, Cavazzana I, Gualdi G, Calzavara-Pinton P, Franceschini F.

Joint Bone Spine. 2015 Mar;82(2):130-1. doi: 10.1016/j.jbspin.2014.05.005. Epub 2014 Jun 27. No abstract available.

PMID:
24986684
43.

In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings.

Venturini M, Arisi M, Zanca A, Cavazzana I, Gonzàlez S, Franceschini F, Calzavara-Pinton P.

Eur J Dermatol. 2014 May-Jun;24(3):349-55. doi: 10.1684/ejd.2014.2321.

PMID:
24721824
44.

Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations.

Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A.

BMC Med. 2014 Mar 3;12:38. doi: 10.1186/1741-7015-12-38. Review.

45.

Rare autoantibodies to cellular antigens in systemic lupus erythematosus.

Fredi M, Cavazzana I, Quinzanini M, Taraborelli M, Cartella S, Tincani A, Franceschini F.

Lupus. 2014 Jun;23(7):672-7. doi: 10.1177/0961203314524850. Epub 2014 Feb 20.

PMID:
24557777
46.

A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.

Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):118-21. Epub 2013 Jul 23.

PMID:
23910615
47.

Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus.

Cartella S, Cavazzana I, Ceribelli A, Inverardi F, Tincani A, Franceschini F.

Autoimmunity. 2013 Sep;46(6):363-8. doi: 10.3109/08916934.2013.794793. Epub 2013 May 24.

PMID:
23706114
48.

Novel aspects of Sjögren's syndrome in 2012.

Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y.

BMC Med. 2013 Apr 4;11:93. doi: 10.1186/1741-7015-11-93. Review.

49.

Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

Taraborelli M, Inverardi F, Fredi M, Ceribelli A, Cavazzana I, Tincani A, Franceschini F.

Reumatismo. 2012 Dec 11;64(5):321-5. doi: 10.4081/reumatismo.2012.321.

PMID:
23256108
50.

Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritis.

Vizzardi E, Cavazzana I, Bazzani C, Pezzali N, Ceribelli A, Bonadei I, Franceschini F, D'Aloia A, Metra M, Tincani A, Cas LD.

J Investig Med. 2012 Dec;60(8):1204-8. doi: 10.2310/JIM.0b013e3182746a83.

PMID:
23111649

Supplemental Content

Loading ...
Support Center